Lux Capital

Founded in 2000, Lux Capital is a venture capital firm based in New York and Silicon Valley. It manages over $5 billion in assets, focusing on seed to growth investments at the intersection of technology and sciences. Lux actively supports entrepreneurs building successful businesses in high-growth sectors such as biochemistry, material science, electronics, infrastructure, aerospace, genomics, synthetic biology, and robotics.

Shahin Farshchi

General Partner

Peter Hebert

Managing Partner

Lan Jiang

Associate

Alex Nguyen

Partner

Ian Peikon

Venture Partner

Brandon Reeves

General Partner

Segolene Scarborough

CFO

Zack Schildhorn

Venture Partner

Deena Shakir

General Partner

Shaquille Vayda

Principal

Shaq Vayda

Principal

Josh Wolfe

Managing Partner

David Yang

Investor

Bilal Zuberi

General Partner

Tess Van Stekelenburg

Partner

Past deals in Eastern US

Ramp

Secondary Market in 2025
Ramp offers a comprehensive financial operations platform designed for businesses seeking to streamline their financial tasks. The platform includes corporate cards, expense management, bill payments, and accounting integrations, assisting organizations in managing their finances efficiently.

Maven Clinic

Series F in 2024
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.

Egenesis

Series D in 2024
Egenesis is a biotechnology company focused on gene editing and genome engineering to develop human-compatible organs, tissues, and cells for transplantation. Its platform enables the creation of solid organs and therapeutic cells intended for transplantation, addressing the global organ shortage. The company pursues programs in kidney and islet cell transplantation and related regenerative approaches. It is based in Cambridge, Massachusetts, with an additional office in New York.

Ramp

Series D in 2024
Ramp offers a comprehensive financial operations platform designed for businesses seeking to streamline their financial tasks. The platform includes corporate cards, expense management, bill payments, and accounting integrations, assisting organizations in managing their finances efficiently.

Vesta Healthcare

Venture Round in 2024
Vesta Healthcare is a technology and clinical services organization based in New York, specializing in connecting caregivers to care teams through its innovative health care platform. The company offers 24/7 telehealth support aimed at caregivers and care recipients, particularly focusing on high-need, frail senior populations. Vesta partners with home care agencies, health plans, and healthcare providers to develop value-based population health programs that prioritize clinical quality and improved health outcomes. Founded in 2008 and originally known as Hometeam Technologies, Inc., Vesta Healthcare has established itself as a leader in enhancing caregiver insights and facilitating personalized engagement in the healthcare setting.

Ramp

Series D in 2023
Ramp offers a comprehensive financial operations platform designed for businesses seeking to streamline their financial tasks. The platform includes corporate cards, expense management, bill payments, and accounting integrations, assisting organizations in managing their finances efficiently.

Chronosphere

Venture Round in 2023
Chronosphere, Inc. is a technology company that specializes in developing an open-source metrics data platform known as M3. Founded in 2019 and headquartered in New York, the company has additional offices in Seattle, Vilnius, and Warsaw. Chronosphere's platform provides comprehensive monitoring solutions for infrastructure, applications, and business metrics, enabling organizations to manage the complexities of cloud-native environments. By offering tools that help DevOps teams quickly identify and resolve issues across various layers of the technology stack, Chronosphere enhances operational reliability and supports data-driven decision-making. The platform is utilized by prominent brands to improve developer productivity, control costs, and enhance customer satisfaction.

Maven Clinic

Series E in 2022
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.

Hugging Face

Series C in 2022
Founded in 2016, Hugging Face is a New York-based company that aims to democratize good machine learning. It provides an open-source platform for collaborating on machine-learning projects, including models, datasets, and applications.

Ramp

Series C in 2022
Ramp offers a comprehensive financial operations platform designed for businesses seeking to streamline their financial tasks. The platform includes corporate cards, expense management, bill payments, and accounting integrations, assisting organizations in managing their finances efficiently.

Pawp

Venture Round in 2022
Pawp, Inc. is a digital health clinic and telehealth platform founded in 2020 and based in New York, New York. The company focuses on providing pet owners with 24/7 access to licensed veterinary professionals, enabling them to manage their pets' health effectively. Pawp's services aim to reduce unnecessary veterinary visits by offering expert consultations online, thereby lowering costs for pet owners. Additionally, the company provides a pet emergency fund of $3,000 per year, acting as a financial safety net for unforeseen veterinary expenses. By combining access to veterinary care and emergency funding, Pawp empowers pet owners to make informed health decisions for their pets.

Kallyope

Series D in 2022
Kallyope Inc. is a biotechnology company based in New York City that focuses on understanding the gut-brain axis to develop innovative therapeutics and consumer products aimed at enhancing human health. Established in 2014, Kallyope employs advanced technologies, including sequencing, computational biology, neural imaging, and human genetics, to explore gut-brain biology. The company aims to address significant unmet medical needs, such as diabetes, obesity, gut disorders, inflammatory diseases, migraines, and allergies, by creating effective and user-friendly oral agents. Kallyope's team consists of experienced scientists from leading institutions, working alongside a skilled team with a strong track record in drug discovery and development. Through its research, Kallyope seeks to deliver transformative solutions that improve overall health outcomes.

Balanced

Seed Round in 2022
Balanced is a digital fitness company focused on healthy aging for older adults. It provides live exercise and mindfulness classes delivered via video, including Zoom, and offers a digital platform with physical therapy assessments, personalized workout schedules, and aging-focused fitness guidance. Founded in 2021 and headquartered in New York, United States, Balanced aims to help older adults maintain a healthy lifestyle through accessible, structured fitness and wellness programs.

Parallel Markets

Series A in 2022
Founded in 2018, Parallel Markets operates an online platform that streamlines investor verification and accreditation for financial platforms. It enables investors to share their credentials across platforms with a single click, simplifying onboarding processes for both individuals and entities while ensuring regulatory compliance.

Anchorage Digital

Series D in 2021
Anchorage Digital is a regulated crypto platform that provides institutions with integrated custody, trading, staking, governance, and regulatory-compliance infrastructure for digital asset programs. Founded in 2017 and headquartered in San Francisco, it serves institutional clients globally with a secure, compliant framework and services designed to simplify oversight and asset management.

H1

Series C in 2021
H1 provides a global healthcare platform that connects life sciences companies, hospitals, academic medical centers, and health systems with providers, enables access to clinical research, helps locate industry experts, and supports benchmarking of organizations. As a trusted source of information on healthcare professionals and institutions, the platform combines real-time data and clinical findings to illuminate the broader healthcare ecosystem. The company, founded in 2017 and based in New York, also offers a healthcare data analytics capability that delivers real-time, end-to-end insights across the data landscape to support therapeutic development—from fundraising and product development to product launch.

Clarifai

Series C in 2021
Founded in 2013, Clarifai specializes in advanced image recognition systems for detecting near-duplicates and enabling visual search. Its platform recognizes various categories, objects, and tags in images, and finds similar images in large uncategorized repositories using a combination of semantic and visual similarity.

Chronosphere

Series C in 2021
Chronosphere, Inc. is a technology company that specializes in developing an open-source metrics data platform known as M3. Founded in 2019 and headquartered in New York, the company has additional offices in Seattle, Vilnius, and Warsaw. Chronosphere's platform provides comprehensive monitoring solutions for infrastructure, applications, and business metrics, enabling organizations to manage the complexities of cloud-native environments. By offering tools that help DevOps teams quickly identify and resolve issues across various layers of the technology stack, Chronosphere enhances operational reliability and supports data-driven decision-making. The platform is utilized by prominent brands to improve developer productivity, control costs, and enhance customer satisfaction.

Kingdom Supercultures

Series A in 2021
Kingdom Supercultures is a Brooklyn-based company established in 2019 that specializes in developing and producing microbial cultures for the food industry. The company focuses on reassembling nature's microbes into innovative combinations, allowing food manufacturers to create new varieties of food with enhanced benefits. Their product line includes Koji, a traditional Japanese ingredient used in miso, sake, and soy sauce, as well as microbial cultures for fermented sodas, beers, and plant-based dairy alternatives. Kingdom Supercultures employs an automated scientific platform that features a comprehensive biobank of Generally Recognized As Safe (GRAS) microbial strains and utilizes advanced algorithms to predict and assemble microbial communities. By providing functional ingredients and biopreservatives, the company aims to support healthy and sustainable food development across various industries, including food, beverage, personal care, and beauty.

Shapeways Holdings

Post in 2021
Shapeways Holdings Inc. is a 3D printing marketplace and community that enables individuals to create, buy, and sell custom products. Founded in 2008 and headquartered in New York, with additional offices in Eindhoven and Seattle, the company offers a wide range of products across various categories, including art, fashion, home goods, gadgets, games, jewelry, and miniatures. Shapeways operates on a model of on-demand printing, allowing for the customization and personalization of each order. By providing access to advanced 3D printing technology, the platform empowers users to turn their ideas into physical products, fostering creativity and entrepreneurship. Shapeways aims to democratize the manufacturing process by fully digitizing it, making industrial-grade additive manufacturing accessible to a broader audience.

Pager

Series C in 2021
Pager, Inc. is a company that operates an on-demand service platform designed to connect patients with healthcare services in various settings including homes, offices, and hotels. The company offers a mobile application that facilitates access to urgent care for a range of conditions such as infections, respiratory issues, and allergies. In addition to its core services, Pager provides nurse chat, teleconsultation, screening, vaccination, and prescription delivery. The company's mission focuses on improving healthcare accessibility, lowering costs, and simplifying care navigation through a flexible platform that integrates artificial intelligence and service teams. Amidst its extensive offerings, Pager supports over 15 million individuals across the United States and Latin America, enabling coordinated care that enhances patient engagement and decision-making. Incorporated in 2013 and headquartered in New York, Pager was previously known as techCare, Inc. before rebranding in 2014.

Statespace

Series C in 2021
StateSpace provides performance analytics and a suite of tools for casual gamers and esports athletes to maximize their potential. It uses cognitive science and artificial intelligence to revolutionize the way humans improve. Leveraging expertise as neuroscientists, data scientists, video game developers, and computer visionaries, the products bring much needed standardized performance analytics to train.It was founded in 2017 and is headquartered in New York, New York.

Ramp

Series C in 2021
Ramp offers a comprehensive financial operations platform designed for businesses seeking to streamline their financial tasks. The platform includes corporate cards, expense management, bill payments, and accounting integrations, assisting organizations in managing their finances efficiently.

Maven Clinic

Series D in 2021
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.

Genvid Technologies

Series C in 2021
Genvid Technologies, Inc. is a software development company specializing in interactive streaming tools tailored for eSports. Founded in 2016 and based in New York City, the company focuses on enabling game developers and broadcasting companies to create unique and engaging streaming experiences. Genvid's technology allows users to customize camera angles, develop real-time streaming compositions, and design viewer interfaces that enhance audience interaction during broadcasts. Additionally, the company's software provides analytics on player statistics, contributing to a more immersive viewing experience. With its developer-grade broadcasting technology integrated with game engines, Genvid Technologies has established itself as a key player in the eSports broadcasting landscape.

Latch

Post in 2021
Latch is a technology company that provides an integrated smart building platform for multifamily properties. It deploys hardware and software to digitize building and unit access and in-unit device control, delivered via a cloud-based software-as-a-service platform known as the Latch Platform. The company offers products including cameras, locks, interconnects, and smart sensors that connect with the platform to manage access and building operations for owners, residents, guests, couriers, and service providers.

Dyno Therapeutics

Series A in 2021
Founded in 2018, Dyno Therapeutics specializes in developing adeno-associated virus (AAV) vectors for in vivo gene therapy delivery. The company's proprietary platform combines DNA synthesis of AAV capsids with sequencing and machine learning to create novel vectors tailored for safe, efficient, and targeted therapeutic solutions.

Pawp

Series A in 2021
Pawp, Inc. is a digital health clinic and telehealth platform founded in 2020 and based in New York, New York. The company focuses on providing pet owners with 24/7 access to licensed veterinary professionals, enabling them to manage their pets' health effectively. Pawp's services aim to reduce unnecessary veterinary visits by offering expert consultations online, thereby lowering costs for pet owners. Additionally, the company provides a pet emergency fund of $3,000 per year, acting as a financial safety net for unforeseen veterinary expenses. By combining access to veterinary care and emergency funding, Pawp empowers pet owners to make informed health decisions for their pets.

Vesta Healthcare

Venture Round in 2021
Vesta Healthcare is a technology and clinical services organization based in New York, specializing in connecting caregivers to care teams through its innovative health care platform. The company offers 24/7 telehealth support aimed at caregivers and care recipients, particularly focusing on high-need, frail senior populations. Vesta partners with home care agencies, health plans, and healthcare providers to develop value-based population health programs that prioritize clinical quality and improved health outcomes. Founded in 2008 and originally known as Hometeam Technologies, Inc., Vesta Healthcare has established itself as a leader in enhancing caregiver insights and facilitating personalized engagement in the healthcare setting.

Hugging Face

Series B in 2021
Founded in 2016, Hugging Face is a New York-based company that aims to democratize good machine learning. It provides an open-source platform for collaborating on machine-learning projects, including models, datasets, and applications.

Anchorage Digital

Series C in 2021
Anchorage Digital is a regulated crypto platform that provides institutions with integrated custody, trading, staking, governance, and regulatory-compliance infrastructure for digital asset programs. Founded in 2017 and headquartered in San Francisco, it serves institutional clients globally with a secure, compliant framework and services designed to simplify oversight and asset management.

Chronosphere

Series B in 2021
Chronosphere, Inc. is a technology company that specializes in developing an open-source metrics data platform known as M3. Founded in 2019 and headquartered in New York, the company has additional offices in Seattle, Vilnius, and Warsaw. Chronosphere's platform provides comprehensive monitoring solutions for infrastructure, applications, and business metrics, enabling organizations to manage the complexities of cloud-native environments. By offering tools that help DevOps teams quickly identify and resolve issues across various layers of the technology stack, Chronosphere enhances operational reliability and supports data-driven decision-making. The platform is utilized by prominent brands to improve developer productivity, control costs, and enhance customer satisfaction.

H1

Series B in 2020
H1 provides a global healthcare platform that connects life sciences companies, hospitals, academic medical centers, and health systems with providers, enables access to clinical research, helps locate industry experts, and supports benchmarking of organizations. As a trusted source of information on healthcare professionals and institutions, the platform combines real-time data and clinical findings to illuminate the broader healthcare ecosystem. The company, founded in 2017 and based in New York, also offers a healthcare data analytics capability that delivers real-time, end-to-end insights across the data landscape to support therapeutic development—from fundraising and product development to product launch.

Workit Health

Series B in 2020
Workit Health provides online therapeutic content and professional counseling services for substance use recovery. It offers Workit, an interactive platform for individuals seeking to reduce or quit alcohol consumption, providing discreet access to on-demand medical and psychosocial support.

Thrive Earlier Detection

Series B in 2020
Thrive Earlier Detection is a healthcare company dedicated to saving lives through early detection of cancer. It develops CancerSEEK, a liquid biopsy test designed to identify various cancers in their earliest stages via blood analysis.

Statespace

Series A in 2020
StateSpace provides performance analytics and a suite of tools for casual gamers and esports athletes to maximize their potential. It uses cognitive science and artificial intelligence to revolutionize the way humans improve. Leveraging expertise as neuroscientists, data scientists, video game developers, and computer visionaries, the products bring much needed standardized performance analytics to train.It was founded in 2017 and is headquartered in New York, New York.

Looking Glass Factory

Series A in 2020
Founded in 2015, Looking Glass Factory develops and manufactures holographic displays designed for 3D creators. Its flagship product, the Looking Glass, combines light field and volumetric display technologies to enable users to create, share, and interact with 3D content without needing VR or AR headsets.

Pager

Series B in 2020
Pager, Inc. is a company that operates an on-demand service platform designed to connect patients with healthcare services in various settings including homes, offices, and hotels. The company offers a mobile application that facilitates access to urgent care for a range of conditions such as infections, respiratory issues, and allergies. In addition to its core services, Pager provides nurse chat, teleconsultation, screening, vaccination, and prescription delivery. The company's mission focuses on improving healthcare accessibility, lowering costs, and simplifying care navigation through a flexible platform that integrates artificial intelligence and service teams. Amidst its extensive offerings, Pager supports over 15 million individuals across the United States and Latin America, enabling coordinated care that enhances patient engagement and decision-making. Incorporated in 2013 and headquartered in New York, Pager was previously known as techCare, Inc. before rebranding in 2014.

Kallyope

Series C in 2020
Kallyope Inc. is a biotechnology company based in New York City that focuses on understanding the gut-brain axis to develop innovative therapeutics and consumer products aimed at enhancing human health. Established in 2014, Kallyope employs advanced technologies, including sequencing, computational biology, neural imaging, and human genetics, to explore gut-brain biology. The company aims to address significant unmet medical needs, such as diabetes, obesity, gut disorders, inflammatory diseases, migraines, and allergies, by creating effective and user-friendly oral agents. Kallyope's team consists of experienced scientists from leading institutions, working alongside a skilled team with a strong track record in drug discovery and development. Through its research, Kallyope seeks to deliver transformative solutions that improve overall health outcomes.

Vesta Healthcare

Series A in 2020
Vesta Healthcare is a technology and clinical services organization based in New York, specializing in connecting caregivers to care teams through its innovative health care platform. The company offers 24/7 telehealth support aimed at caregivers and care recipients, particularly focusing on high-need, frail senior populations. Vesta partners with home care agencies, health plans, and healthcare providers to develop value-based population health programs that prioritize clinical quality and improved health outcomes. Founded in 2008 and originally known as Hometeam Technologies, Inc., Vesta Healthcare has established itself as a leader in enhancing caregiver insights and facilitating personalized engagement in the healthcare setting.

Evolv Technology

Series C in 2020
Evolv Technology specializes in touchless security screening systems, ensuring safety without compromising visitor experience. Headquartered in Waltham, Massachusetts, the company offers advanced solutions integrating real-time video surveillance with low false alarms, firearm and explosive detection, facial recognition, and security analytics.

Adimab

Venture Round in 2020
Adimab LLC is a biotechnology company specializing in the discovery, development, and optimization of human monoclonal and bispecific antibodies. Founded in 2007 and based in Lebanon, New Hampshire, Adimab utilizes a yeast-based platform to create therapeutic antibodies, including IgG and CD3-based bispecific antibodies. The company is recognized for its ability to deliver diverse and high-quality antibody panels that adhere to stringent standards for affinity, epitope coverage, and species cross-reactivity. This capability allows Adimab to support its partners in rapidly expanding their biologics pipelines through various technology access arrangements. The company's work primarily targets the treatment of cancer, autoimmune disorders, and infectious diseases.

Hugging Face

Series A in 2019
Founded in 2016, Hugging Face is a New York-based company that aims to democratize good machine learning. It provides an open-source platform for collaborating on machine-learning projects, including models, datasets, and applications.

Onaroll

Pre Seed Round in 2019
Founded in 2019, Onaroll is a technology company based in New York City. It operates an employee rewards platform designed to enhance shift worker retention by incentivizing productivity and longevity through performance-based rewards.

Chronosphere

Series A in 2019
Chronosphere, Inc. is a technology company that specializes in developing an open-source metrics data platform known as M3. Founded in 2019 and headquartered in New York, the company has additional offices in Seattle, Vilnius, and Warsaw. Chronosphere's platform provides comprehensive monitoring solutions for infrastructure, applications, and business metrics, enabling organizations to manage the complexities of cloud-native environments. By offering tools that help DevOps teams quickly identify and resolve issues across various layers of the technology stack, Chronosphere enhances operational reliability and supports data-driven decision-making. The platform is utilized by prominent brands to improve developer productivity, control costs, and enhance customer satisfaction.

Evolv Technology

Series C in 2019
Evolv Technology specializes in touchless security screening systems, ensuring safety without compromising visitor experience. Headquartered in Waltham, Massachusetts, the company offers advanced solutions integrating real-time video surveillance with low false alarms, firearm and explosive detection, facial recognition, and security analytics.

Statespace

Seed Round in 2019
StateSpace provides performance analytics and a suite of tools for casual gamers and esports athletes to maximize their potential. It uses cognitive science and artificial intelligence to revolutionize the way humans improve. Leveraging expertise as neuroscientists, data scientists, video game developers, and computer visionaries, the products bring much needed standardized performance analytics to train.It was founded in 2017 and is headquartered in New York, New York.

CTRL-Labs

Venture Round in 2019
CTRL-Labs develops neural interface technologies that enable humans to interact with machines using natural movements and thoughts. Their flagship product, CTRL-kit, is a wireless, non-invasive electromyography device that translates neural signals into control for applications in XR, robotics, productivity, and clinical research.

Zipdrug

Venture Round in 2019
Zipdrug, Inc. is a technology company that has developed an application aimed at simplifying the process of ordering prescribed medications. Founded in 2015 and based in New York City, the company provides a platform that connects patients with a curated network of pharmacies, allowing for the delivery of prescriptions directly to their homes. This service is particularly beneficial for Medicare and Medicaid members, as it facilitates access to low-cost pharmacies and promotes medication adherence through personalized care. By eliminating the waiting time typically associated with traditional pharmacy visits, Zipdrug enhances the overall patient experience in managing their prescriptions. As of July 2020, Zipdrug operates as a subsidiary of IngenioRx, Inc.

Workit Health

Series A in 2019
Workit Health provides online therapeutic content and professional counseling services for substance use recovery. It offers Workit, an interactive platform for individuals seeking to reduce or quit alcohol consumption, providing discreet access to on-demand medical and psychosocial support.

Kallyope

Series B in 2018
Kallyope Inc. is a biotechnology company based in New York City that focuses on understanding the gut-brain axis to develop innovative therapeutics and consumer products aimed at enhancing human health. Established in 2014, Kallyope employs advanced technologies, including sequencing, computational biology, neural imaging, and human genetics, to explore gut-brain biology. The company aims to address significant unmet medical needs, such as diabetes, obesity, gut disorders, inflammatory diseases, migraines, and allergies, by creating effective and user-friendly oral agents. Kallyope's team consists of experienced scientists from leading institutions, working alongside a skilled team with a strong track record in drug discovery and development. Through its research, Kallyope seeks to deliver transformative solutions that improve overall health outcomes.

Vesta Healthcare

Series A in 2018
Vesta Healthcare is a technology and clinical services organization based in New York, specializing in connecting caregivers to care teams through its innovative health care platform. The company offers 24/7 telehealth support aimed at caregivers and care recipients, particularly focusing on high-need, frail senior populations. Vesta partners with home care agencies, health plans, and healthcare providers to develop value-based population health programs that prioritize clinical quality and improved health outcomes. Founded in 2008 and originally known as Hometeam Technologies, Inc., Vesta Healthcare has established itself as a leader in enhancing caregiver insights and facilitating personalized engagement in the healthcare setting.

Latch

Series B in 2018
Latch is a technology company that provides an integrated smart building platform for multifamily properties. It deploys hardware and software to digitize building and unit access and in-unit device control, delivered via a cloud-based software-as-a-service platform known as the Latch Platform. The company offers products including cameras, locks, interconnects, and smart sensors that connect with the platform to manage access and building operations for owners, residents, guests, couriers, and service providers.

CTRL-Labs

Series B in 2018
CTRL-Labs develops neural interface technologies that enable humans to interact with machines using natural movements and thoughts. Their flagship product, CTRL-kit, is a wireless, non-invasive electromyography device that translates neural signals into control for applications in XR, robotics, productivity, and clinical research.

Shapeways Holdings

Series E in 2018
Shapeways Holdings Inc. is a 3D printing marketplace and community that enables individuals to create, buy, and sell custom products. Founded in 2008 and headquartered in New York, with additional offices in Eindhoven and Seattle, the company offers a wide range of products across various categories, including art, fashion, home goods, gadgets, games, jewelry, and miniatures. Shapeways operates on a model of on-demand printing, allowing for the customization and personalization of each order. By providing access to advanced 3D printing technology, the platform empowers users to turn their ideas into physical products, fostering creativity and entrepreneurship. Shapeways aims to democratize the manufacturing process by fully digitizing it, making industrial-grade additive manufacturing accessible to a broader audience.

Kyruus

Corporate Round in 2018
Kyruus, Inc. is a Boston-based company that develops web-based software solutions aimed at optimizing physician networks for hospitals, health systems, and life science companies. Founded in 2010, Kyruus offers a suite of analytically driven products designed to enhance provider search and scheduling, ensuring that patients are matched with the most suitable healthcare providers. Key offerings include Kyruus Passport, which allows physicians to track their activity and productivity, and Kyruus Profiles, which enables administrators to analyze physician performance metrics. Additionally, the company provides Kyruus MDSeekyr, a platform for identifying high-value providers, and Kyruus Insight Reports, which help executives evaluate network activity and performance trends. By leveraging a proprietary provider data management platform, Kyruus enhances patient engagement and aligns provider supply with patient demand, ultimately improving the overall healthcare experience. Kyruus also maintains offices in San Francisco and New York.

Kallyope

Series B in 2018
Kallyope Inc. is a biotechnology company based in New York City that focuses on understanding the gut-brain axis to develop innovative therapeutics and consumer products aimed at enhancing human health. Established in 2014, Kallyope employs advanced technologies, including sequencing, computational biology, neural imaging, and human genetics, to explore gut-brain biology. The company aims to address significant unmet medical needs, such as diabetes, obesity, gut disorders, inflammatory diseases, migraines, and allergies, by creating effective and user-friendly oral agents. Kallyope's team consists of experienced scientists from leading institutions, working alongside a skilled team with a strong track record in drug discovery and development. Through its research, Kallyope seeks to deliver transformative solutions that improve overall health outcomes.

Pager

Series A in 2018
Pager, Inc. is a company that operates an on-demand service platform designed to connect patients with healthcare services in various settings including homes, offices, and hotels. The company offers a mobile application that facilitates access to urgent care for a range of conditions such as infections, respiratory issues, and allergies. In addition to its core services, Pager provides nurse chat, teleconsultation, screening, vaccination, and prescription delivery. The company's mission focuses on improving healthcare accessibility, lowering costs, and simplifying care navigation through a flexible platform that integrates artificial intelligence and service teams. Amidst its extensive offerings, Pager supports over 15 million individuals across the United States and Latin America, enabling coordinated care that enhances patient engagement and decision-making. Incorporated in 2013 and headquartered in New York, Pager was previously known as techCare, Inc. before rebranding in 2014.

Visor

Seed Round in 2017
Visor Inc. is an online tax filing and advisory service that caters specifically to urban professionals. Established in 2016 and headquartered in San Francisco, California, the company has expanded its presence with additional locations across major cities in the United States, including Miami, New York, Philadelphia, and Los Angeles, among others. Visor provides comprehensive services that include the preparation of annual tax returns and year-round tax advice, aiming to make tax advisory accessible to a broader audience. The company's focus is on delivering tailored support to meet the diverse needs of its clients, ensuring they receive expert guidance throughout the tax year.

Citizen

Series A in 2017
Citizen is a mobile application that sends safety alerts and real-time incident updates to its users. It operates across major US markets, providing millions of people with information sourced from 911 data, live stories, and user-generated content. The app aims to enhance personal and community safety.

Desktop Metal

Series D in 2017
Desktop Metal is a global developer and manufacturer of additive manufacturing technologies, materials, and software for industrial production. The company offers a range of metal 3D printing systems, including the Production System for high-volume manufacturing, the Shop System for machine shops, the Studio System for office environments, and the Fiber printer for desktop use. It supplies materials and software that support metal, polymer, sand, and ceramic applications, enabling on-demand, digital mass production with improved speed, cost efficiency, and part quality. Desktop Metal serves automotive, aerospace, healthcare, consumer products, heavy industry, machine design, and research and development customers and operates worldwide from headquarters in Burlington, Massachusetts.

Latch

Series A in 2017
Latch is a technology company that provides an integrated smart building platform for multifamily properties. It deploys hardware and software to digitize building and unit access and in-unit device control, delivered via a cloud-based software-as-a-service platform known as the Latch Platform. The company offers products including cameras, locks, interconnects, and smart sensors that connect with the platform to manage access and building operations for owners, residents, guests, couriers, and service providers.

Drone Racing League

Series B in 2017
Drone Racing League Inc., established in New York in 2015, specializes in staging professional drone races for top-tier pilots. The company hosts thrilling tournaments featuring first-person perspective drone racing, where elite pilots navigate custom-built drones through intricate, themed 3D courses. DRL generates revenue by selling tickets to these events and offering media services related to its high-octane competitions.

Evolv Technology

Series B in 2017
Evolv Technology specializes in touchless security screening systems, ensuring safety without compromising visitor experience. Headquartered in Waltham, Massachusetts, the company offers advanced solutions integrating real-time video surveillance with low false alarms, firearm and explosive detection, facial recognition, and security analytics.

Looking Glass Factory

Series A in 2017
Founded in 2015, Looking Glass Factory develops and manufactures holographic displays designed for 3D creators. Its flagship product, the Looking Glass, combines light field and volumetric display technologies to enable users to create, share, and interact with 3D content without needing VR or AR headsets.

Desktop Metal

Series C in 2017
Desktop Metal is a global developer and manufacturer of additive manufacturing technologies, materials, and software for industrial production. The company offers a range of metal 3D printing systems, including the Production System for high-volume manufacturing, the Shop System for machine shops, the Studio System for office environments, and the Fiber printer for desktop use. It supplies materials and software that support metal, polymer, sand, and ceramic applications, enabling on-demand, digital mass production with improved speed, cost efficiency, and part quality. Desktop Metal serves automotive, aerospace, healthcare, consumer products, heavy industry, machine design, and research and development customers and operates worldwide from headquarters in Burlington, Massachusetts.

Alluvium

Seed Round in 2016
Alluvium, Inc. is a Brooklyn-based technology company founded in 2015 that develops IoT and AI solutions for industrial operations. Its platform provides real‑time operational insights, a Stability Score, and geolocation services that enhance worker safety, productivity, and compliance. The company integrates reliable hardware and software, including video analytics, to digitize safety equipment and enable factories to improve efficiency and competitiveness. It operates as a subsidiary of Augury Inc.

Clarifai

Series B in 2016
Founded in 2013, Clarifai specializes in advanced image recognition systems for detecting near-duplicates and enabling visual search. Its platform recognizes various categories, objects, and tags in images, and finds similar images in large uncategorized repositories using a combination of semantic and visual similarity.

Workit Health

Seed Round in 2016
Workit Health provides online therapeutic content and professional counseling services for substance use recovery. It offers Workit, an interactive platform for individuals seeking to reduce or quit alcohol consumption, providing discreet access to on-demand medical and psychosocial support.

Desktop Metal

Series B in 2016
Desktop Metal is a global developer and manufacturer of additive manufacturing technologies, materials, and software for industrial production. The company offers a range of metal 3D printing systems, including the Production System for high-volume manufacturing, the Shop System for machine shops, the Studio System for office environments, and the Fiber printer for desktop use. It supplies materials and software that support metal, polymer, sand, and ceramic applications, enabling on-demand, digital mass production with improved speed, cost efficiency, and part quality. Desktop Metal serves automotive, aerospace, healthcare, consumer products, heavy industry, machine design, and research and development customers and operates worldwide from headquarters in Burlington, Massachusetts.

Kala Pharmaceuticals

Series C in 2016
Kala Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to developing and commercializing innovative therapies for eye diseases using its proprietary Mucus Penetrating Particles (MPP) technology. This technology enhances drug distribution and pharmacokinetics by coating mucosal surfaces with biocompatible, drug-loaded particles, allowing for improved local drug concentrations while minimizing systemic exposure. Kala's lead product candidate, KPI-121 0.25%, has completed two Phase III clinical trials aimed at providing temporary relief for dry eye disease. Additionally, INVELTYS has also completed two Phase III trials for managing inflammation and pain after ocular surgery. The company is advancing KPI-285, a receptor tyrosine kinase inhibitor, in preclinical studies targeting retinal diseases. Established in 2009 and headquartered in Watertown, Massachusetts, Kala Pharmaceuticals continues to explore diverse product opportunities while focusing on internal development and research collaborations to address significant clinical needs.

Kallyope

Series A in 2015
Kallyope Inc. is a biotechnology company based in New York City that focuses on understanding the gut-brain axis to develop innovative therapeutics and consumer products aimed at enhancing human health. Established in 2014, Kallyope employs advanced technologies, including sequencing, computational biology, neural imaging, and human genetics, to explore gut-brain biology. The company aims to address significant unmet medical needs, such as diabetes, obesity, gut disorders, inflammatory diseases, migraines, and allergies, by creating effective and user-friendly oral agents. Kallyope's team consists of experienced scientists from leading institutions, working alongside a skilled team with a strong track record in drug discovery and development. Through its research, Kallyope seeks to deliver transformative solutions that improve overall health outcomes.

Zipdrug

Seed Round in 2015
Zipdrug, Inc. is a technology company that has developed an application aimed at simplifying the process of ordering prescribed medications. Founded in 2015 and based in New York City, the company provides a platform that connects patients with a curated network of pharmacies, allowing for the delivery of prescriptions directly to their homes. This service is particularly beneficial for Medicare and Medicaid members, as it facilitates access to low-cost pharmacies and promotes medication adherence through personalized care. By eliminating the waiting time typically associated with traditional pharmacy visits, Zipdrug enhances the overall patient experience in managing their prescriptions. As of July 2020, Zipdrug operates as a subsidiary of IngenioRx, Inc.

Looking Glass Factory

Seed Round in 2015
Founded in 2015, Looking Glass Factory develops and manufactures holographic displays designed for 3D creators. Its flagship product, the Looking Glass, combines light field and volumetric display technologies to enable users to create, share, and interact with 3D content without needing VR or AR headsets.

Desktop Metal

Series A in 2015
Desktop Metal is a global developer and manufacturer of additive manufacturing technologies, materials, and software for industrial production. The company offers a range of metal 3D printing systems, including the Production System for high-volume manufacturing, the Shop System for machine shops, the Studio System for office environments, and the Fiber printer for desktop use. It supplies materials and software that support metal, polymer, sand, and ceramic applications, enabling on-demand, digital mass production with improved speed, cost efficiency, and part quality. Desktop Metal serves automotive, aerospace, healthcare, consumer products, heavy industry, machine design, and research and development customers and operates worldwide from headquarters in Burlington, Massachusetts.

Kyruus

Series C in 2015
Kyruus, Inc. is a Boston-based company that develops web-based software solutions aimed at optimizing physician networks for hospitals, health systems, and life science companies. Founded in 2010, Kyruus offers a suite of analytically driven products designed to enhance provider search and scheduling, ensuring that patients are matched with the most suitable healthcare providers. Key offerings include Kyruus Passport, which allows physicians to track their activity and productivity, and Kyruus Profiles, which enables administrators to analyze physician performance metrics. Additionally, the company provides Kyruus MDSeekyr, a platform for identifying high-value providers, and Kyruus Insight Reports, which help executives evaluate network activity and performance trends. By leveraging a proprietary provider data management platform, Kyruus enhances patient engagement and aligns provider supply with patient demand, ultimately improving the overall healthcare experience. Kyruus also maintains offices in San Francisco and New York.

Pager

Series A in 2015
Pager, Inc. is a company that operates an on-demand service platform designed to connect patients with healthcare services in various settings including homes, offices, and hotels. The company offers a mobile application that facilitates access to urgent care for a range of conditions such as infections, respiratory issues, and allergies. In addition to its core services, Pager provides nurse chat, teleconsultation, screening, vaccination, and prescription delivery. The company's mission focuses on improving healthcare accessibility, lowering costs, and simplifying care navigation through a flexible platform that integrates artificial intelligence and service teams. Amidst its extensive offerings, Pager supports over 15 million individuals across the United States and Latin America, enabling coordinated care that enhances patient engagement and decision-making. Incorporated in 2013 and headquartered in New York, Pager was previously known as techCare, Inc. before rebranding in 2014.

Clarifai

Series A in 2015
Founded in 2013, Clarifai specializes in advanced image recognition systems for detecting near-duplicates and enabling visual search. Its platform recognizes various categories, objects, and tags in images, and finds similar images in large uncategorized repositories using a combination of semantic and visual similarity.

Pager

Venture Round in 2015
Pager, Inc. is a company that operates an on-demand service platform designed to connect patients with healthcare services in various settings including homes, offices, and hotels. The company offers a mobile application that facilitates access to urgent care for a range of conditions such as infections, respiratory issues, and allergies. In addition to its core services, Pager provides nurse chat, teleconsultation, screening, vaccination, and prescription delivery. The company's mission focuses on improving healthcare accessibility, lowering costs, and simplifying care navigation through a flexible platform that integrates artificial intelligence and service teams. Amidst its extensive offerings, Pager supports over 15 million individuals across the United States and Latin America, enabling coordinated care that enhances patient engagement and decision-making. Incorporated in 2013 and headquartered in New York, Pager was previously known as techCare, Inc. before rebranding in 2014.

Sols

Series B in 2015
Sols, Inc., established in 2013 and headquartered in New York, specializes in customized orthotic solutions for foot support. The company offers two primary products: SOLSRx, medical-grade 3D printed orthotics, and ExoSOLS, direct-to-consumer custom insoles. Sols' innovative approach combines software, mobile applications, and advanced technologies like computer vision and machine learning to create tailored footwear solutions that address alignment issues, promote proper gait, and relieve plantar fascia pressure. The company serves customers in the United States and is a subsidiary of Aetrex Worldwide, Inc.

Toonimo

Venture Round in 2014
Toonimo Inc. is a New York-based company founded in 2013 that specializes in developing a digital adoption platform designed to enhance user experience through interactive audio-visual guidance solutions. The company's technology integrates seamlessly with various software systems, including Salesforce, Microsoft Dynamics, and Oracle CRM, facilitating internal employee training and customer onboarding. Toonimo's platform allows users to learn in real-time by providing step-by-step guidance through text bubbles, voice prompts, and visual cues, thereby creating an effective self-service environment. This approach not only improves user adoption of software but also leads to significant cost savings in training, enhanced employee morale, and increased operational efficiency. Toonimo serves a diverse range of industries, including finance, healthcare, telecommunications, education, and hospitality, positioning itself as a key player in the realm of user experience and digital transformation.

Pager

Venture Round in 2014
Pager, Inc. is a company that operates an on-demand service platform designed to connect patients with healthcare services in various settings including homes, offices, and hotels. The company offers a mobile application that facilitates access to urgent care for a range of conditions such as infections, respiratory issues, and allergies. In addition to its core services, Pager provides nurse chat, teleconsultation, screening, vaccination, and prescription delivery. The company's mission focuses on improving healthcare accessibility, lowering costs, and simplifying care navigation through a flexible platform that integrates artificial intelligence and service teams. Amidst its extensive offerings, Pager supports over 15 million individuals across the United States and Latin America, enabling coordinated care that enhances patient engagement and decision-making. Incorporated in 2013 and headquartered in New York, Pager was previously known as techCare, Inc. before rebranding in 2014.

Sols

Series A in 2014
Sols, Inc., established in 2013 and headquartered in New York, specializes in customized orthotic solutions for foot support. The company offers two primary products: SOLSRx, medical-grade 3D printed orthotics, and ExoSOLS, direct-to-consumer custom insoles. Sols' innovative approach combines software, mobile applications, and advanced technologies like computer vision and machine learning to create tailored footwear solutions that address alignment issues, promote proper gait, and relieve plantar fascia pressure. The company serves customers in the United States and is a subsidiary of Aetrex Worldwide, Inc.

Kala Pharmaceuticals

Series B in 2014
Kala Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to developing and commercializing innovative therapies for eye diseases using its proprietary Mucus Penetrating Particles (MPP) technology. This technology enhances drug distribution and pharmacokinetics by coating mucosal surfaces with biocompatible, drug-loaded particles, allowing for improved local drug concentrations while minimizing systemic exposure. Kala's lead product candidate, KPI-121 0.25%, has completed two Phase III clinical trials aimed at providing temporary relief for dry eye disease. Additionally, INVELTYS has also completed two Phase III trials for managing inflammation and pain after ocular surgery. The company is advancing KPI-285, a receptor tyrosine kinase inhibitor, in preclinical studies targeting retinal diseases. Established in 2009 and headquartered in Watertown, Massachusetts, Kala Pharmaceuticals continues to explore diverse product opportunities while focusing on internal development and research collaborations to address significant clinical needs.

Sols

Seed Round in 2013
Sols, Inc., established in 2013 and headquartered in New York, specializes in customized orthotic solutions for foot support. The company offers two primary products: SOLSRx, medical-grade 3D printed orthotics, and ExoSOLS, direct-to-consumer custom insoles. Sols' innovative approach combines software, mobile applications, and advanced technologies like computer vision and machine learning to create tailored footwear solutions that address alignment issues, promote proper gait, and relieve plantar fascia pressure. The company serves customers in the United States and is a subsidiary of Aetrex Worldwide, Inc.

Visterra

Series A in 2013
Visterra is a clinical-stage biopharmaceutical company developing precision antibody-based medicines for hard-to-treat infectious and non-infectious diseases. It uses its Hierotope platform to engineer monoclonal antibodies targeting various pathogens, including influenza A, dengue virus, Pseudomonas aeruginosa, and Immunoglobulin A Nephropathy.

Evolv Technology

Series A in 2013
Evolv Technology specializes in touchless security screening systems, ensuring safety without compromising visitor experience. Headquartered in Waltham, Massachusetts, the company offers advanced solutions integrating real-time video surveillance with low false alarms, firearm and explosive detection, facial recognition, and security analytics.

Shapeways Holdings

Series C in 2013
Shapeways Holdings Inc. is a 3D printing marketplace and community that enables individuals to create, buy, and sell custom products. Founded in 2008 and headquartered in New York, with additional offices in Eindhoven and Seattle, the company offers a wide range of products across various categories, including art, fashion, home goods, gadgets, games, jewelry, and miniatures. Shapeways operates on a model of on-demand printing, allowing for the customization and personalization of each order. By providing access to advanced 3D printing technology, the platform empowers users to turn their ideas into physical products, fostering creativity and entrepreneurship. Shapeways aims to democratize the manufacturing process by fully digitizing it, making industrial-grade additive manufacturing accessible to a broader audience.

Kala Pharmaceuticals

Series A in 2013
Kala Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to developing and commercializing innovative therapies for eye diseases using its proprietary Mucus Penetrating Particles (MPP) technology. This technology enhances drug distribution and pharmacokinetics by coating mucosal surfaces with biocompatible, drug-loaded particles, allowing for improved local drug concentrations while minimizing systemic exposure. Kala's lead product candidate, KPI-121 0.25%, has completed two Phase III clinical trials aimed at providing temporary relief for dry eye disease. Additionally, INVELTYS has also completed two Phase III trials for managing inflammation and pain after ocular surgery. The company is advancing KPI-285, a receptor tyrosine kinase inhibitor, in preclinical studies targeting retinal diseases. Established in 2009 and headquartered in Watertown, Massachusetts, Kala Pharmaceuticals continues to explore diverse product opportunities while focusing on internal development and research collaborations to address significant clinical needs.

Kyruus

Series B in 2013
Kyruus, Inc. is a Boston-based company that develops web-based software solutions aimed at optimizing physician networks for hospitals, health systems, and life science companies. Founded in 2010, Kyruus offers a suite of analytically driven products designed to enhance provider search and scheduling, ensuring that patients are matched with the most suitable healthcare providers. Key offerings include Kyruus Passport, which allows physicians to track their activity and productivity, and Kyruus Profiles, which enables administrators to analyze physician performance metrics. Additionally, the company provides Kyruus MDSeekyr, a platform for identifying high-value providers, and Kyruus Insight Reports, which help executives evaluate network activity and performance trends. By leveraging a proprietary provider data management platform, Kyruus enhances patient engagement and aligns provider supply with patient demand, ultimately improving the overall healthcare experience. Kyruus also maintains offices in San Francisco and New York.

Visterra

Series A in 2012
Visterra is a clinical-stage biopharmaceutical company developing precision antibody-based medicines for hard-to-treat infectious and non-infectious diseases. It uses its Hierotope platform to engineer monoclonal antibodies targeting various pathogens, including influenza A, dengue virus, Pseudomonas aeruginosa, and Immunoglobulin A Nephropathy.

Genocea Biosciences

Series C in 2012
Genocea Biosciences, Inc. is a biopharmaceutical company based in Cambridge, Massachusetts, focused on the discovery and development of innovative cancer immunotherapies and vaccines. Utilizing its proprietary ATLAS platform, the company profiles patient-specific CD4+ and CD8+ T cell immune responses to identify potential antigens in tumors. This technology enables Genocea to develop personalized immuno-oncology programs, including GEN-009, an adjuvanted neoantigen peptide vaccine currently in phase I/IIa clinical trials, as well as GEN-011, a neoantigen adoptive T cell therapy, and GEN-010, a neoantigen vaccine program. Additionally, the company has pursued immunotherapies for other diseases, such as GEN-003, aimed at treating genital herpes, and it maintains a pre-clinical program focused on personalized cancer vaccines. Founded in 2006, Genocea is dedicated to addressing significant unmet medical needs through its advanced therapeutic approaches.

Shapeways Holdings

Series B in 2012
Shapeways Holdings Inc. is a 3D printing marketplace and community that enables individuals to create, buy, and sell custom products. Founded in 2008 and headquartered in New York, with additional offices in Eindhoven and Seattle, the company offers a wide range of products across various categories, including art, fashion, home goods, gadgets, games, jewelry, and miniatures. Shapeways operates on a model of on-demand printing, allowing for the customization and personalization of each order. By providing access to advanced 3D printing technology, the platform empowers users to turn their ideas into physical products, fostering creativity and entrepreneurship. Shapeways aims to democratize the manufacturing process by fully digitizing it, making industrial-grade additive manufacturing accessible to a broader audience.

Kala Pharmaceuticals

Private Equity Round in 2012
Kala Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to developing and commercializing innovative therapies for eye diseases using its proprietary Mucus Penetrating Particles (MPP) technology. This technology enhances drug distribution and pharmacokinetics by coating mucosal surfaces with biocompatible, drug-loaded particles, allowing for improved local drug concentrations while minimizing systemic exposure. Kala's lead product candidate, KPI-121 0.25%, has completed two Phase III clinical trials aimed at providing temporary relief for dry eye disease. Additionally, INVELTYS has also completed two Phase III trials for managing inflammation and pain after ocular surgery. The company is advancing KPI-285, a receptor tyrosine kinase inhibitor, in preclinical studies targeting retinal diseases. Established in 2009 and headquartered in Watertown, Massachusetts, Kala Pharmaceuticals continues to explore diverse product opportunities while focusing on internal development and research collaborations to address significant clinical needs.

Madaket

Seed Round in 2012
Madaket, Inc. is a Cambridge, Massachusetts-based company that specializes in developing SaaS solutions for the healthcare industry. The company focuses on automating the healthcare enrollment process, facilitating connections between healthcare providers and payers to streamline administrative tasks. With a robust platform designed to manage provider data, Madaket enables healthcare organizations to save time and reduce manual errors while effectively tracking enrollment statuses. The company has established exclusive partnerships with notable entities such as TriZetto Provider Solutions and HealthStream, allowing it to support over 300,000 providers and an additional 325,000 providers under contract. Founded in 2012 by Mads Kvalsvik, Scott Soderstrom, Jim Dougherty, Benedict Dsilva, and Ted Achtem, Madaket aims to enhance efficiency in healthcare administration.

Genocea Biosciences

Series B in 2011
Genocea Biosciences, Inc. is a biopharmaceutical company based in Cambridge, Massachusetts, focused on the discovery and development of innovative cancer immunotherapies and vaccines. Utilizing its proprietary ATLAS platform, the company profiles patient-specific CD4+ and CD8+ T cell immune responses to identify potential antigens in tumors. This technology enables Genocea to develop personalized immuno-oncology programs, including GEN-009, an adjuvanted neoantigen peptide vaccine currently in phase I/IIa clinical trials, as well as GEN-011, a neoantigen adoptive T cell therapy, and GEN-010, a neoantigen vaccine program. Additionally, the company has pursued immunotherapies for other diseases, such as GEN-003, aimed at treating genital herpes, and it maintains a pre-clinical program focused on personalized cancer vaccines. Founded in 2006, Genocea is dedicated to addressing significant unmet medical needs through its advanced therapeutic approaches.

Visterra

Debt Financing in 2010
Visterra is a clinical-stage biopharmaceutical company developing precision antibody-based medicines for hard-to-treat infectious and non-infectious diseases. It uses its Hierotope platform to engineer monoclonal antibodies targeting various pathogens, including influenza A, dengue virus, Pseudomonas aeruginosa, and Immunoglobulin A Nephropathy.

Genocea Biosciences

Series B in 2009
Genocea Biosciences, Inc. is a biopharmaceutical company based in Cambridge, Massachusetts, focused on the discovery and development of innovative cancer immunotherapies and vaccines. Utilizing its proprietary ATLAS platform, the company profiles patient-specific CD4+ and CD8+ T cell immune responses to identify potential antigens in tumors. This technology enables Genocea to develop personalized immuno-oncology programs, including GEN-009, an adjuvanted neoantigen peptide vaccine currently in phase I/IIa clinical trials, as well as GEN-011, a neoantigen adoptive T cell therapy, and GEN-010, a neoantigen vaccine program. Additionally, the company has pursued immunotherapies for other diseases, such as GEN-003, aimed at treating genital herpes, and it maintains a pre-clinical program focused on personalized cancer vaccines. Founded in 2006, Genocea is dedicated to addressing significant unmet medical needs through its advanced therapeutic approaches.

Visterra

Seed Round in 2009
Visterra is a clinical-stage biopharmaceutical company developing precision antibody-based medicines for hard-to-treat infectious and non-infectious diseases. It uses its Hierotope platform to engineer monoclonal antibodies targeting various pathogens, including influenza A, dengue virus, Pseudomonas aeruginosa, and Immunoglobulin A Nephropathy.

Genocea Biosciences

Series A in 2009
Genocea Biosciences, Inc. is a biopharmaceutical company based in Cambridge, Massachusetts, focused on the discovery and development of innovative cancer immunotherapies and vaccines. Utilizing its proprietary ATLAS platform, the company profiles patient-specific CD4+ and CD8+ T cell immune responses to identify potential antigens in tumors. This technology enables Genocea to develop personalized immuno-oncology programs, including GEN-009, an adjuvanted neoantigen peptide vaccine currently in phase I/IIa clinical trials, as well as GEN-011, a neoantigen adoptive T cell therapy, and GEN-010, a neoantigen vaccine program. Additionally, the company has pursued immunotherapies for other diseases, such as GEN-003, aimed at treating genital herpes, and it maintains a pre-clinical program focused on personalized cancer vaccines. Founded in 2006, Genocea is dedicated to addressing significant unmet medical needs through its advanced therapeutic approaches.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.